PDCD1 and non-small cell lung carcinoma: This study will focus on discussing the application value of PET metabolic parameters and the aforementioned related hematological indicators in the prognosis of survival of advanced NSCLC patients who received PD-1/PD-L1 ICIs in combination or without chemotherapy.